MRK - Company ID 0000310158
The table below shows Merck & Co., Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.56B | $13.24B | $6.84B | $12.69B | $8.10B | $8.06B |
| Short-term investments | $0.00 | $447.00M | $252.00M | $498.00M | - | $0.00 |
| Receivables | $11.78B | $10.28B | $10.35B | $9.45B | $9.23B | $7.85B |
| Inventory | $6.66B | $6.11B | $6.36B | $5.91B | $5.95B | $6.31B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $43.52B |
| $38.78B |
| $32.17B |
| $35.72B |
| $30.27B |
| $27.76B |
| Property, plant & equipment | $25.32B | $23.78B | $23.05B | $21.42B | $19.28B | $17.99B |
| Goodwill | $21.58B | $21.67B | $21.20B | $21.20B | $21.26B | $20.24B |
| Total assets | $136.87B | $117.11B | $106.67B | $109.16B | $105.69B | $91.59B |
| Accounts payable | $4.40B | $4.08B | $3.92B | $4.26B | $4.61B | $4.59B |
| Total current liabilities | $28.33B | $28.42B | $25.69B | $24.24B | $23.87B | $27.33B |
| Long-term debt | $46.75B | $34.46B | $33.68B | $28.75B | $30.69B | $25.36B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $73.08B | $63.07B | $53.90B | $61.08B | $53.70B | $47.36B |
| Total equity | $52.61B | $46.31B | $37.58B | $45.99B | $38.18B | $25.32B |